Jin, K., Xu, J., Su, X., Xu, Z., Li, B., Liu, G., . . . Xu, J. (2024). TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma. Wiley. https://doi.org/10.1002/path.6266
Chicago Style (17th ed.) CitationJin, Kaifeng, et al. TP53 Disruptive Mutation Predicts Platinum‐based Chemotherapy and PD‐1/PD‐L1 Blockade Response in Urothelial Carcinoma. Wiley, 2024. https://doi.org/10.1002/path.6266.
MLA (9th ed.) CitationJin, Kaifeng, et al. TP53 Disruptive Mutation Predicts Platinum‐based Chemotherapy and PD‐1/PD‐L1 Blockade Response in Urothelial Carcinoma. Wiley, 2024. https://doi.org/10.1002/path.6266.
Warning: These citations may not always be 100% accurate.